VOLORIDGE INVESTMENT MANAGEMENT, LLC
Position in GPCR — Structure Therapeutics Inc.
CIK 1556921
JUPITER, FL
Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,289,505
-$5,097,995 QoQ
Shares Held
254,969
+2.0% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VOLORIDGE INVESTMENT MANAGEMENT, LLC holds $554,830,833 across 41 Biotechnology names. GPCR ranks #16 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
189,217 | $62,606,228 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
672,858 | $50,524,907 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
368,325 | $35,819,606 | |
| 4 | EXEL |
Exelixis, Inc.
|
787,674 | $33,783,337 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
426,583 | $31,678,053 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
1,426,834 | $29,892,172 | |
| 7 | BNTX |
BioNTech SE
|
307,864 | $27,362,952 | |
| 8 | ASND |
Ascendis Pharma A/S
|
114,275 | $26,138,120 |
All Filings in GPCR
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,289,505 | 254,969 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $17,387,500 | 250,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||